Treatment of recalcitrant warts with intralesional measles, mumps, and rubella vaccine: A promising approach

International Journal of Dermatology

Volumn 54, Issue 6, 2015, Pages 667-671

  Nofal, Ahmad ^a   Nofal, Eman ^a   Yosef, Ayman ^a   Nofal, Hager ^a  

^a ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE; NONSTEROID ANTIINFLAMMATORY AGENT; RETINOIC ACID; SALICYLIC ACID; TRICHLOROACETIC ACID; ZINC;

ADULT; ARTICLE; CAUTERIZATION; CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL TRIAL; CRYOTHERAPY; CURETTAGE; DISEASE DURATION; DRUG CLEARANCE; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EXCISION; FEMALE; FLU LIKE SYNDROME; FOLLOW UP; HUMAN; INJECTION SITE EDEMA; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE PRURITUS; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; RECALCITRANT WART; RECURRENCE RISK; RECURRENT DISEASE; SKIN SENSITIZATION; TREATMENT RESPONSE; VACCINATION; VACCINATION REACTION; VERRUCA VULGARIS; ADOLESCENT; IMMUNOTHERAPY; INTRALESIONAL DRUG ADMINISTRATION; MIDDLE AGED; WARTS; YOUNG ADULT;

ADOLESCENT; ADULT; FEMALE; HUMANS; IMMUNOTHERAPY; INJECTIONS, INTRALESIONAL; MALE; MEASLES-MUMPS-RUBELLA VACCINE; MIDDLE AGED; RECURRENCE; WARTS; YOUNG ADULT;

EID: 84929606200     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/ijd.12480     Document Type: Article

References (25)

1. Rivera A, Tyring SK. Therapy of cutaneous human papillomavirus infections. Dermatol Ther 2004; 17: 441-448.
2. Bacelieri R, Johnson SM. Cutaneous warts: an evidence-based approach to therapy. Am Fam Physician 2005; 72: 647-652.
3. Lipke MM. An armamentarium of wart treatments. Clin Med Res 2006; 4: 273-293.
4. Massing AM, Epstein WL. Natural history of warts: a two-year study. Arch Dermatol 1963; 87: 306-310.
5. Cobb MW. Human papillomavirus infection. J Am Acad Dermatol 1990; 22: 547-566.
6. Micali G, Dall'Oglio F, Nasca MR, et al. Management of cutaneous warts: an evidence-based approach. Am J Clin Dermatol 2004; 5: 311-317.
7. Leung L. Recalcitrant nongenital warts. Aust Fam Physician 2011; 40: 40-42.
8. Goihman-Yahr M, Goldblum OM. Immunotherapy and warts: a point of view. Clin Dermatol 2008; 26: 223-225.
9. Mulhem E, Pinelis S. Treatment of nongenital cutaneous warts. Am Fam Physician 2011; 84: 288-293.
10. Venugopal SS, Murrell DF. Recalcitrant cutaneous warts treated with recombinant quadrivalent human papillomavirus vaccine (types 6, 11, 16, and 18) in a developmentally delayed, 31-year-old white man. Arch Dermatol 2010; 146: 475-477.
11. Su JZ, Tu JC. Experience with treatment of warts by acupuncture and its evaluation. J Tradit Chin Med 1987; 7: 199-202.
12. Phillips RC, Ruhl TS, Pfenniger JL, et al. Treatment of warts with Candida antigen injection. Arch Dermatol 2000; 136: 1274-1275.
13. Johnson SM, Roberson PK, Horn TD. Intralesional injection of mumps or Candida skin test antigens: a novel immunotherapy for warts. Arch Dermatol 2001; 137: 451-455.
14. Signore RJ. Candida albicans intralesional injection immunotherapy of warts. Cutis 2002; 70: 185-192.
15. Clifton MM, Johnson SM, Roberson PK, et al. Immunotherapy for recalcitrant warts in children using intralesional mumps or Candida antigens. Pediatr Dermatol 2003; 20: 268-271.
16. Johnson SM, Horn TD. Intralesional immunotherapy for warts using a combination of skin test antigens: a safe and effective therapy. J Drugs Dermatol 2004; 3: 263-265.
17. King M, Johnson SM, Horn TD. Intralesional immunotherapy for genital warts. Arch Dermatol 2005; 141: 1606-1607.
18. Kus S, Ergun T, Gun D, et al. Intralesional tuberculin for treatment of refractory warts. J Eur Acad Dermatol Venereol 2005; 19: 515-516.
19. Horn TD, Johnson SM, Helm RM, et al. Intralesional immunotherapy of warts with mumps, Candida and trichophyton skin test antigens: a single-blinded, randomized and controlled trial. Arch Dermatol 2005; 141: 589-594.
20. Gupta S, Malhotra AK, Verma KK, et al. Intralesional immunotherapy with killed Mycobacterium w vaccine for the treatment of ano-genital warts: an open label pilot study. J Eur Acad Dermatol Venereol 2008; 22: 1089-1093.
21. Wananukul S, Chatproedprai S, Kittiratsacha P. Intralesional immunotherapy using tuberculin PPD in the treatment of palmoplantar and periungual warts. Asian Biomed 2009; 3: 739-743.
22. Nofal A, Nofal E. Intralesional immunotherapy of common warts: successful treatment with mumps, measles and rubella vaccine. J Eur Acad Dermatol Venereol 2010; 63: 1166-1170.
23. Choi H, Kim HR, Na CH, et al. Intralesional immunotherapy of warts with mumps, measles and rubella vaccine. J Dermatol 2012; 39(Suppl. 1): 63-64.
24. Salem A, Nofal A, Hosny D. Treatment of common and plane warts in children with topical viable bacillus Calmette-Guerin. Pediatr Dermatol 2013; 30: 60-63.
25. Chandrashekar L. Intralesional immunotherapy for the management of warts. Indian J Dermatol Venereol Leprol 2011; 77: 261-263.